Two studies explored the quality-of-life impacts of lebrikizumab for atopic dermatitis, finding its benefits extend beyond ...

A new study conducted by researchers at National Jewish Health has found that early changes in the cheek skin barrier may ...

Treatment with JAK inhibitors was associated with a greater risk of infections compared with biologic therapies in patients with atopic dermatitis.

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

Atopic dermatitis—the most common type of eczema—can look very different on darker skin tones. As someone living with the ...

LEO Pharma has reported positive topline outcomes from the randomised Phase IIb trial of the IL-22 receptor subunit alpha 1 ...

The incidence and prevalence of atopic dermatitis among older adults increased from 1990 to 2021, although age-standardized rates decreased.